Global Fidaxomicin Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Fidaxomicin is also termed as Difimicin, or Tiacumicin B, or Lipiarmicin, or Lipiarrmycin, or Lipiarmycin. It is a macrolide antibacterial drug specified for the treatment of Clostridium Difficile-Associated Diarrhea. The antibiotic Fidaxomicin drug kills bacteria in the intestines. Mais
